| Revenue growth | 22% YoY growth to ₹1,388 crore, driven by formulation business. |
|---|---|
| Margins | EBITDA margins improved 200bps YoY to 22.2% on better mix. |
| Demand visibility | Strong growth in North America and Europe formulation segments. |
| Management confidence | Confident, focusing on regulatory resolution and higher complexity generic launches. |
Growth
Revenue grew 22% YoY to ₹1,388 crore; EBITDA margins rose by 200bps to 22.2% despite CDMO drag.
Outlook
Management expects CDMO business to turn EBITDA positive in Q4FY26 with meaningful performance improvement.
Risks
Regulatory overhang remains at Gagillapur facility; CDMO business is still in a loss-making gestation phase.
Earnings Call filed with NSE, NSE: GRANULES. Summary written with AI assistance from the document.
Granules India Ltd: key numbers
- Share price
- ₹868.65
- Market cap
- ₹21,525 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 32.5×Sector 50.4×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Promoter Buying
Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India Ltd via the open market. This transaction increases the promoter stake by 8.70%.
- Promoter stake change
- +8.70%
Granules India Other Announcement
The company submitted its quarterly shareholding pattern disclosure as required by SEBI regulations for the period ended September 16, 2026.
Granules India Capital Structure Change
Granules India allotted 2.49 crore equity shares to its promoter group upon warrant conversion, raising Rs. 1,461.50 Crore. This increases the company's total paid-up equity capital.
- Value
- ₹1,462 Cr
Granules India Capital Structure Change
Granules India received Rs. 1,093 crore from the Promoter group, representing the balance 75% subscription for the conversion of 2.49 crore warrants into equity shares.
- Value
- ₹1,093 Cr
Granules India Promoter Selling
Promoter Dr. Krishna Prasad Chigurupati sold 1.72 crore equity shares of Granules India Ltd via block deal and open market, reducing aggregate promoter stake.
- Promoter stake change
- -6.94%
Granules India Earnings Call Transcript: Key Takeaways
Granules India Q1 FY27 results show strong performance with Revenue growing 22% YoY and PAT up 60%, driven by a significant mix shift towards high-margin Complex Generics.